Association between serum lipoprotein(a) and mildly reduced eGFR: a cross-sectional study
Authors:
Open Access
- 8 December 2023
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 24 (1) , 1-10
Abstract
Lipoprotein(a) [Lp(a)] is a risk factor for cardiovascular disease (CVD) and aortic stenosis. However, the data on the relationship between Lp(a) and mildly reduced estimated glomerular filtration rate (eGFR) has been disputed. This study was conducted to assess the relationship between Lp(a) concentrations and mildly reduced eGFR in healthy subjects.This community-based, cross-sectional study enrolled 1,064 volunteers aged ≥ 40 years who lived in Yonghong Community, Zhonglou District, Changzhou, China, between December 2016 and December 2017. A mildly reduced eGFR was defined as eGFR between 60 and 90 mL/min/1.73m2. A standardized questionnaire and biochemical measurements were used to gather information about participants. The serum concentration of Lp(a) was determined using the latex-enhanced immunoturbidimetric test. Of the total study population, 34.8% (n = 370) were men, and the mean age was 66.8 ± 8.5 years. A significant association existed between Lp(a) levels and the risk of mildly reduced eGFR. Individuals with the highest tertile of Lp(a) had higher odds of mildly reduced eGFR after adjusting for various confounders (adjusted odds ratio [OR]: 1.80, 95% confidence interval [CI]: 1.24–2.60, P = 0.0025) compared to those with the lowest tertile of Lp(a). Multivariable logistic regression of studies in which Lp(a) was presented as continuous variables showed consistent results (adjusted OR: 1.23 for 1-SD increment of Ln-Lp(a), 95% CI: 1.05–1.43). Subgroup analyses showed that study characteristics such as age, sex, obesity, diabetes, and hypertension status did not significantly affect the association (P for all interactions > 0.05). These results suggest that higher serum Lp(a) level was an independent risk factor for mildly reduced eGFR.Keywords
Funding Information
- Changzhou Key Research and Development Project (CE20205022)
- Changzhou Health Commision Young Talents Project (QN202018)
- Changzhou Sci&Tech Program (CJ20220063)
- Young Talent Development Plan of Changzhou Health Commission (CZQM2020007)
- Top Talent of Changzhou “the 14th Five-Year Plan” High-Level Health Talents Training Projects (2022260)
This publication has 47 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- TGF Expression and Macrophage Accumulation in Atherosclerotic Renal Artery StenosisClinical Journal of the American Society of Nephrology, 2013
- NoticeKidney International Supplements, 2013
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CNew England Journal of Medicine, 2012
- A Risk Score for Chronic Kidney Disease in the General PopulationThe American Journal of Medicine, 2012
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Predictors of New-Onset Kidney Disease in a Community-Based PopulationJAMA, 2004
- Increased Serum Lipoprotein(a) Levels in Patients with Early Renal FailureAnnals of Internal Medicine, 1998
- Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.Journal of Clinical Investigation, 1994